Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer

Fig. 1

BC069792 expression in breast cancer tissue. a The expression of LncRNA BC069792 in breast cancer tissue was significantly lower than that in adjacent normal breast tissue, the difference was statistically significant, P < 0.001. b The results of ROC curve analysis showed that BC069792 distinguished breast cancer tissue from normal breast tissue, the area under the curve was 0.9191, and the P value was < 0.0001. c In the MDA-MB-231 cell line, about 27.6% of BC069792 was expressed in the cytoplasm and 72.4% in the nucleus. In the MDA-MB-468 cell line, about 26.4% of BC069792 was expressed in the cytoplasm and 73.6% in the nucleus. d The results of RNA FISH assay showed that BC069792 was distributed in both nucleus and cytoplasm in MDA-MB-468 cell line. e Stability assay of BC069792 in MDA-MB-231 and MDA-MB-468 (P < 0.05, P < 0.01, P < 0.001,. P < 0.0001, ns P > 0.05)**********

Back to article page